Annual Cash & Cash Equivalents
$143.43 M
-$96.80 M-40.30%
December 31, 2021
Summary
- As of February 10, 2025, CLVS annual cash & cash equivalents is $143.43 million, with the most recent change of -$96.80 million (-40.30%) on December 31, 2021.
- During the last 3 years, CLVS annual cash & cash equivalents has fallen by -$78.45 million (-35.36%).
Performance
CLVS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$58.32 M
-$36.26 M-38.34%
September 30, 2022
Summary
- As of February 10, 2025, CLVS quarterly cash and cash equivalents is $58.32 million, with the most recent change of -$36.26 million (-38.34%) on September 30, 2022.
- Over the past year, CLVS quarterly cash and cash equivalents has dropped by -$113.63 million (-66.08%).
Performance
CLVS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLVS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.3% | -66.1% |
| 3 y3 years | -35.4% | -71.0% |
| 5 y5 years | -69.1% | -90.5% |
CLVS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -59.3% | at low |
| 5 y | 5-year | -40.3% | at low | -77.7% | at low |
| alltime | all time | -70.3% | -92.7% | -90.5% | -92.1% |
Clovis Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $58.32 M(-38.3%) |
| Jun 2022 | - | $94.58 M(-22.6%) |
| Mar 2022 | - | $122.24 M(-14.8%) |
| Dec 2021 | $143.43 M(-40.3%) | $143.43 M(-16.6%) |
| Sep 2021 | - | $171.95 M(-25.3%) |
| Jun 2021 | - | $230.20 M(+20.6%) |
| Mar 2021 | - | $190.92 M(-20.5%) |
| Dec 2020 | $240.23 M(+48.4%) | $240.23 M(+6.9%) |
| Sep 2020 | - | $224.70 M(-14.1%) |
| Jun 2020 | - | $261.44 M(+60.1%) |
| Mar 2020 | - | $163.31 M(+0.9%) |
| Dec 2019 | $161.83 M(-27.1%) | $161.83 M(-19.7%) |
| Sep 2019 | - | $201.48 M(+85.5%) |
| Jun 2019 | - | $108.61 M(-11.9%) |
| Mar 2019 | - | $123.31 M(-44.4%) |
| Dec 2018 | $221.88 M(-52.2%) | $221.88 M(-23.7%) |
| Sep 2018 | - | $290.85 M(-37.9%) |
| Jun 2018 | - | $468.32 M(+25.2%) |
| Mar 2018 | - | $374.11 M(-19.4%) |
| Dec 2017 | $464.20 M(+114.7%) | $464.20 M(-24.1%) |
| Sep 2017 | - | $611.47 M(+24.3%) |
| Jun 2017 | - | $491.79 M(+78.2%) |
| Mar 2017 | - | $276.05 M(+27.7%) |
| Dec 2016 | $216.19 M | $216.19 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $243.72 M(+6.7%) |
| Jun 2016 | - | $228.38 M(+3.6%) |
| Mar 2016 | - | $220.37 M(-20.9%) |
| Dec 2015 | $278.76 M(-42.2%) | $278.76 M(-21.6%) |
| Sep 2015 | - | $355.44 M(+50.4%) |
| Jun 2015 | - | $236.26 M(-19.0%) |
| Mar 2015 | - | $291.54 M(-39.6%) |
| Dec 2014 | $482.68 M(+49.3%) | $482.68 M(-6.6%) |
| Sep 2014 | - | $516.59 M(+89.1%) |
| Jun 2014 | - | $273.23 M(-10.0%) |
| Mar 2014 | - | $303.65 M(-6.1%) |
| Dec 2013 | $323.23 M(+124.3%) | $323.23 M(-9.4%) |
| Sep 2013 | - | $356.62 M(-4.2%) |
| Jun 2013 | - | $372.24 M(+187.1%) |
| Mar 2013 | - | $129.63 M(-10.0%) |
| Dec 2012 | $144.10 M(+4.2%) | $144.10 M(-11.3%) |
| Sep 2012 | - | $162.48 M(-8.2%) |
| Jun 2012 | - | $176.90 M(+46.2%) |
| Mar 2012 | - | $120.98 M(-12.5%) |
| Dec 2011 | $138.24 M(+1215.5%) | $138.24 M(+591.5%) |
| Sep 2011 | - | $19.99 M(-25.6%) |
| Jun 2011 | - | $26.87 M(+483.9%) |
| Mar 2011 | - | $4.60 M(-56.2%) |
| Dec 2010 | $10.51 M | $10.51 M |
FAQ
- What is Clovis Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Clovis Oncology?
- What is Clovis Oncology annual cash & cash equivalents year-on-year change?
- What is Clovis Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Clovis Oncology?
- What is Clovis Oncology quarterly cash and cash equivalents year-on-year change?
What is Clovis Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of CLVS is $143.43 M
What is the all time high annual cash & cash equivalents for Clovis Oncology?
Clovis Oncology all-time high annual cash & cash equivalents is $482.68 M
What is Clovis Oncology annual cash & cash equivalents year-on-year change?
Over the past year, CLVS annual cash & cash equivalents has changed by -$96.80 M (-40.30%)
What is Clovis Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLVS is $58.32 M
What is the all time high quarterly cash and cash equivalents for Clovis Oncology?
Clovis Oncology all-time high quarterly cash and cash equivalents is $611.47 M
What is Clovis Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, CLVS quarterly cash and cash equivalents has changed by -$113.63 M (-66.08%)